Literature DB >> 31049330

Malignant Eyelid Tumors in India: A Study of 536 Asian Indian Patients.

Swathi Kaliki1, Nandini Bothra1, Kavya Madhuri Bejjanki1, Arpita Nayak1, George Ramappa1, Ashik Mohamed2, Tarjani Vivek Dave1, Mohammad Javed Ali1, Milind N Naik1.   

Abstract

PURPOSE: To study the proportion of eyelid malignant tumors in an Asian Indian population and to review their clinical features and outcomes.
METHODS: This is a retrospective study of 536 patients.
RESULTS: The mean age at presentation with eyelid malignancy was 58 years. Histopathology-proven diagnoses of these patients included sebaceous gland carcinoma (SGC) (n = 285, 53%), basal cell carcinoma (BCC) (n = 128, 24%), squamous cell carcinoma (SCC) (n = 99, 18%), and miscellaneous tumors (n = 24, 4%). The statistically significant differences between eyelid malignant tumors included age at presentation, tumor location, and tumor extent. The clinicopathological correlation of SGC, BCC, SCC, and miscellaneous tumors was 91, 86, 46, and 38% (p = 0.001), respectively. Comparing SGC with BCC, SCC, and miscellaneous tumors, SGC was more commonly associated with tumor recurrence (21 vs. 3, 8, and 13%; p = 0.001), systemic metastasis (13 vs. 0, 4, and 13%; p = 0.001), and death (9 vs. 0, 4, and 0%; p = 0.004). Compared to SGC, BCC, and SCC, locoregional lymph node metastasis was more common with miscellaneous tumors (26 vs. 16, < 1, and 8%; p = 0.001) over a mean follow-up period of 19 months.
CONCLUSION: In Asian Indians, SGC is twice as common as BCC and 3 times more common than SCC. SGC is associated with poorer prognosis compared to other eyelid malignant tumors.

Entities:  

Keywords:  Asian Indian population; Basal cell carcinoma; Eyelid malignant tumors; Miscellaneous tumors; Sebaceous gland carcinoma; Squamous cell carcinoma

Year:  2018        PMID: 31049330      PMCID: PMC6489076          DOI: 10.1159/000491549

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  38 in total

Review 1.  Sebaceous carcinoma of the ocular region: a review.

Authors:  Jerry A Shields; Hakan Demirci; Brian P Marr; Ralph C Eagle; Carol L Shields
Journal:  Surv Ophthalmol       Date:  2005 Mar-Apr       Impact factor: 6.048

2.  Eye cancer incidence in Singapore.

Authors:  S B Lee; K G Au Eong; S M Saw; T K Chan; H P Lee
Journal:  Br J Ophthalmol       Date:  2000-07       Impact factor: 4.638

3.  Clinicopathological analysis of malignant eyelid tumor cases at Yamagata university hospital: statistical comparison of tumor incidence in Japan and in other countries.

Authors:  Hiroshi Takamura; Hidetoshi Yamashita
Journal:  Jpn J Ophthalmol       Date:  2005 Sep-Oct       Impact factor: 2.447

Review 4.  [Incidence of benign and malignant lesions of eyelid and conjunctival tumors].

Authors:  Hiroto Obata; Yuki Aoki; Shunsuke Kubota; Nobuyuki Kanai; Tadahiko Tsuru
Journal:  Nippon Ganka Gakkai Zasshi       Date:  2005-09

Review 5.  Basal cell carcinomas of the eyelids.

Authors:  J Allali; F D'Hermies; G Renard
Journal:  Ophthalmologica       Date:  2005 Mar-Apr       Impact factor: 3.250

6.  [Histopathology studies on 8,673 cases of ocular adnexal hyperplastic lesions and tumors].

Authors:  J Dai; X Sun; B Li; B Zheng; S Hu; L Li; Y Chen; C Chen
Journal:  Zhonghua Yan Ke Za Zhi       Date:  1999-07

7.  Malignant eyelid tumours in Taiwan.

Authors:  J-K Wang; S-L Liao; J-R Jou; P-C Lai; S C S Kao; P-K Hou; M-S Chen
Journal:  Eye (Lond)       Date:  2003-03       Impact factor: 3.775

8.  Eyelid tumors in southern Taiwan: a 5-year survey from a medical university.

Authors:  Cheng-Hsien Chang; Sheng-Ming Chang; Yu-Hung Lai; Jason Huang; Ming-Yang Su; Hwei-Zu Wang; Yi-Tseng Liu
Journal:  Kaohsiung J Med Sci       Date:  2003-11       Impact factor: 2.744

9.  Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota.

Authors:  B E Cook; G B Bartley
Journal:  Ophthalmology       Date:  1999-04       Impact factor: 12.079

10.  [Pigmented epitheliomas of the eyelids].

Authors:  C Haye; J L Dufier
Journal:  Arch Ophtalmol (Paris)       Date:  1976-10
View more
  9 in total

Review 1.  Malignant lesions of the caruncle.

Authors:  Pav Gounder; Dinesh Selva; Saul N Rajak
Journal:  Eye (Lond)       Date:  2022-06-21       Impact factor: 3.775

2.  Neoadjuvant Systemic Chemotherapy in Sebaceous Gland Carcinoma of the Eyelid: A Retrospective Study.

Authors:  Saurav Verma; Nipun Kumar; Rachna Meel; Seema Sen; Seema Kashyap; Sanjay Sharma; Neelam Pushker; Deepam Pushpam; Sameer Bakhshi
Journal:  Ocul Oncol Pathol       Date:  2021-05-05

3.  Characteristics and Recurrence of Primary Eyelid Basal Cell Carcinoma in Central Spain.

Authors:  Alicia Galindo-Ferreiro; Hortensia Sanchez-Tocino; Cecilia Diez-Montero; Minal Belani-Raju; Raquel García-Sanz; Miguel Diego-Alonso; Ines Llorente-Gonzalez; Patricia Callejo Perez; Rajiv Khandekar; Silvana Schellini
Journal:  J Curr Ophthalmol       Date:  2020-04-30

4.  Clinicopathological Analysis and Demographic Features of Ocular Malignancies.

Authors:  Abdullah Al-Mujaini; Rajendra Prakash Maurya; Sanjay Bosak; Manish Kumar Karan; Meghna Roy; Virendra Pratap Singh; Mahendra Kumar Singh; Ajay Kumar; Samer Singh
Journal:  Clin Ophthalmol       Date:  2021-01-29

5.  Ocular and Periocular Tumors in India: An EyeSmart Electronic Medical Record Analysis of 9633 Cases from a Referral Center.

Authors:  Swathi Kaliki; Anthony V Das
Journal:  Middle East Afr J Ophthalmol       Date:  2021-01-19

6.  Evaluation of Demographic Features of Eyelid Lesions.

Authors:  Korhan Fazil; Safak Karslioglu; Muslime Akbaba; Ibrahim Bulent Buttanri; Didem Serin; Gamze Ozturk Karabulut; Damla Bektasoglu
Journal:  Beyoglu Eye J       Date:  2020-06-04

7.  Clinicopathological Analysis and Surgical Outcome of Eyelid Malignancies: A Study of 332 Cases.

Authors:  Syeed Mehbub Ul Kadir; Mukti Rani Mitra; Riffat Rashid; Murtuza Nuruddin; Md Kamrul Hassan Khan; Golam Haider; Mst Sayedatun Nessa
Journal:  J Skin Cancer       Date:  2022-02-18

8.  The spectrum and clinicopathological correlation of eyelid lesions: Twenty years' experience at a tertiary eye care center in South India.

Authors:  Prabrisha Banerjee; Kirthi Koka; Md Shahid Alam; Nirmala Subramanian; Jyotirmay Biswas; Subramanian Krishnakumar; Bipasha Mukherjee
Journal:  Indian J Ophthalmol       Date:  2022-01       Impact factor: 1.848

9.  Malignant tumors of the eyelid in India: A multicenter, multizone study on clinicopathologic features and outcomes.

Authors:  Roshmi Gupta; Anirban Bhaduri; Savari Desai; Sima Das; Vikas Menon
Journal:  Indian J Ophthalmol       Date:  2020-11       Impact factor: 1.848

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.